Assertio (ASRT)
(Real Time Quote from BATS)
$1.23 USD
+0.03 (2.50%)
Updated Jun 26, 2024 03:44 PM ET
3-Hold of 5 3
C Value B Growth D Momentum B VGM
Brokerage Reports
0 items in cart
Assertio Holdings, Inc. [ASRT]
Reports for Purchase
Showing records 101 - 116 ( 116 total )
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Deep Value - Even with Conservative Assumptions
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
1Q19 Recap - Cosyntropin Noise, But Valuation Remains Compelling
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Purdue Settlement a Positive (Despite ST Reaction)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Updated Model - Modest Downward Revisions, but Still Undervalued
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.